Table 2. Practice Recommendations and Level of Evidence
Practice RecommendationsLevel of EvidenceReference
Give pneumococcal polysaccharide vaccine (PSV23, Pneumovax) for prevention of pneumococcal disease to following persons:
    Immunocompetent persons and persons aged ≥65 years of age.A54
    Persons aged 2–64 years with chronic cardiovascular disease, chronic pulmonary disease, or diabetes mellitus.A54
    Persons aged 2–64 years with alcoholism, chronic liver disease, or cerebrospinal fluid leaks.B54
Give herpes zoster vaccine (Zostavax) for the prevention of herpes zoster and its complications in persons ≥60 years without contraindications.A55